Compare HOUR & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | BTMD |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.3M | 64.4M |
| IPO Year | 2021 | 2021 |
| Metric | HOUR | BTMD |
|---|---|---|
| Price | $1.98 | $2.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 18.0K | ★ 140.0K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.57 | N/A |
| EPS | 0.07 | ★ 0.68 |
| Revenue | $138,252,861.00 | ★ $197,191,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.37 |
| P/E Ratio | $28.14 | ★ $3.09 |
| Revenue Growth | 4.64 | ★ 6.38 |
| 52 Week Low | $1.10 | $2.02 |
| 52 Week High | $6.84 | $4.90 |
| Indicator | HOUR | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.92 | 40.47 |
| Support Level | $1.73 | $2.02 |
| Resistance Level | $1.95 | $2.91 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 50.45 | 20.34 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.